Bryan M. Reasons Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bryan M. Reasons.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Bryan M. Reasons for May 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,849 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,849 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,849 | 0 | 15,032 | 6.2 K to 15 K (+143.12 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,849 | 0 | 15,032 | 6.2 K to 15 K (+143.12 %) |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 0.00 | 33,311 | 0 | 33,311 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 15.01 | 136,240 | 2,044,962 | 136,240 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 17.99 | 52,000 | 935,480 | 52,000 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 25.24 | 55,000 | 1,388,200 | 55,000 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 40.70 | 47,500 | 1,933,250 | 47,500 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 33.27 | 63,095 | 2,099,171 | 63,095 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
| May 08 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Grant | A | 0.00 | 94,684 | 0 | 94,684 | 0 to 94.7 K |
| May 08 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 17.99 | 52,000 | 935,480 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 25.24 | 55,000 | 1,388,200 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 40.70 | 47,500 | 1,933,250 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 33.27 | 63,095 | 2,099,171 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Sell | D | 0.00 | 20,566 | 0 | 0 | 20.6 K to 0 (-100.00 %) |
| May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Sell | D | 0.00 | 53,423 | 0 | 0 | 53.4 K to 0 (-100.00 %) |